Progan studies against CMV disease on hold.
D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D011355:Prodrugs / Q000627:therapeutic use*
D000998:Antiviral Agents; D011355:Prodrugs; D015774:Ganciclovir